Oppenheimer & Co’s PROLOR Biotech, Inc. Common Stock PBTH Stock Holding History

Oppenheimer & Co’s Portfolio PBTH Stock Details PBTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-32,128	Closed	-$202K	–	1433
2013 Q2	$202K	Buy	+32,128	New	+$192K	0.01%	1105

Other funds holding PBTH

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

CDH

Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Oppenheimer & Co's PBTH Position: Q3 2013 in Review

Oppenheimer & Co sold out of PROLOR Biotech, Inc. Common Stock (PBTH) in Q3 2013, closing a stake of 32,128 shares — an estimated $202K sold.

Oppenheimer & Co first reported a position in PBTH in Q2 2013 and held it in 1 quarter. The position peaked at $202K in Q2 2013. 3 funds tracked by Wall St. Rank hold PBTH as of Q3 2013.

Oppenheimer & Co reported no remaining PROLOR Biotech, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
Oppenheimer & Co sold 32,128 PROLOR Biotech, Inc. Common Stock shares in Q3 2013, an estimated $202K.
Oppenheimer & Co first reported a position in PROLOR Biotech, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
Oppenheimer & Co's PROLOR Biotech, Inc. Common Stock position peaked at $202K in Q2 2013.
3 funds tracked by Wall St. Rank held PROLOR Biotech, Inc. Common Stock as of Q3 2013.

Based on Oppenheimer & Co's 13F filing for Q3 2013, filed 1 Nov 2013.